NovaBay Pharmaceuticals Stock (AMEX: NBY) stock price, news, charts, stock research, profile.
Open | $0.070 |
Close | $0.077 |
Volume / Avg. | 1.564M / 3.513M |
Day Range | 0.068 - 0.079 |
52 Wk Range | 0.065 - 1.950 |
Market Cap | $2.614M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 26 |
Short Interest | 1.99% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NovaBay Pharmaceuticals (AMEX: NBY) through any online brokerage.
Other companies in NovaBay Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Processa Pharma (NASDAQ:PCSA), cbdMD (AMEX:YCBD), 60 Degrees (NASDAQ:SXTP) and Akanda (NASDAQ:AKAN).
The latest price target for NovaBay Pharmaceuticals (AMEX: NBY) was reported by Ladenburg Thalmann on Friday, August 11, 2023. The analyst firm set a price target for 3.80 expecting NBY to rise to within 12 months (a possible 4959.92% upside). 1 analyst firms have reported ratings in the last year.
The stock price for NovaBay Pharmaceuticals (AMEX: NBY) is $0.0751 last updated Today at April 23, 2024 at 4:45 PM EDT.
There are no upcoming dividends for NovaBay Pharmaceuticals.
NovaBay Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for NovaBay Pharmaceuticals.
NovaBay Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the AMEX.